Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients

• Published in: Familial cancer 2009-12, Vol.8 (4), p.489-500
• Main Authors: Christensen, Lise Lotte, Kariola, Reetta, Korhonen, Mari K., Wikman, Friedrik P., Sunde, Lone, Gerdes, Anne-Marie, Okkels, Henrik, Brandt, Carsten A., Bernstein, Inge, Hansen, Thomas V. O., Hagemann-Madsen, Rikke, Andersen, Claus L., Nyström, Minna, Ørntoft, Torben F.
• Format: Article
• Language: English
• Subjects: Adaptor Proteins, Signal Transducing - genetics; Adult; Biomedical and Life Sciences; Biomedicine; Blotting, Western; Cancer Research; Colorectal Neoplasms - genetics; Denmark; Epidemiology; Female; Human Genetics; Humans; Male; Middle Aged; Mutagenesis, Site-Directed; Mutation, Missense; MutL Protein Homolog 1; MutS Homolog 2 Protein - genetics; Nuclear Proteins - genetics; Pedigree
• ISSN: 1389-9600; 1573-7292
• DOI: 10.1007/s10689-009-9274-4

Recently, we have performed a population based study to analyse the frequency of colorectal cancer related MLH1 and MSH2 missense mutations in the Danish population. Half of the analyzed mutations were rare and most likely only present in the families where they were identified originally. Some of the missense mutations were located in conserved regions in the MLH1 and MSH2 proteins indicating a relation to disease development. In the present study, we functionally characterized 10 rare missense mutations in MLH1 and MSH2 identified in 13 Danish CRC families. To elucidate the pathogenicity of the missense mutations, we carried out in vitro functional analyses. The missense mutations were analyzed for their effect on protein expression and repair efficiency. The results of the functional analysis were correlated with clinical data on the families carrying these mutations. Eight missense mutations resulted in proteins with expression and repair efficiency similar to the wild type. One missense mutation (MSH2 p.Met688Val) caused reduced protein expression and one (MSH2 p.Leu187Arg) caused both reduced protein expression and repair deficiency. The MSH2 p.Leu187Arg mutation was found in an Amsterdam II family presenting with high microsatellite instability and loss of MSH2 and MSH6 proteins in tumours. In conclusion, only 1/10 missense mutations displayed repair deficiency and could be classified as pathogenic. No final conclusion can be drawn on the MSH2 p.Met688Val mutation, which caused reduced protein expression. Although, no deficiencies have been identified in the proteins harbouring the other missense mutations, pathogenicity of these variants cannot be unambiguously excluded.